The demand for oxytocin in Japan is projected to grow from USD 5.1 billion in 2025 to USD 9.3 billion by 2035, at a CAGR of 6.2%. Postpartum will dominate with a 86.0% market share, while hospital pharmacies will lead the distribution channel segment with a 64.5% share.